Your browser doesn't support javascript.
loading
Identification of Novel Cyclooxygenase-1 Selective Inhibitors of Thiadiazole-Based Scaffold as Potent Anti-Inflammatory Agents with Safety Gastric and Cytotoxic Profile.
Haroun, Michelyne; Fesatidou, Maria; Petrou, Anthi; Tratrat, Christophe; Zagaliotis, Panagiotis; Gavalas, Antonis; Venugopala, Katharigatta N; Kochkar, Hafedh; Emeka, Promise M; Younis, Nancy S; Elmaghraby, Dalia Ahmed; Almostafa, Mervt M; Chohan, Muhammad Shahzad; Vizirianakis, Ioannis S; Papadimitriou-Tsantarliotou, Aliki; Geronikaki, Athina.
Affiliation
  • Haroun M; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
  • Fesatidou M; School of Pharmacy, Aristotle, University of Thessaloniki, 54124 Thessaloniki, Greece.
  • Petrou A; School of Pharmacy, Aristotle, University of Thessaloniki, 54124 Thessaloniki, Greece.
  • Tratrat C; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
  • Zagaliotis P; School of Pharmacy, Aristotle, University of Thessaloniki, 54124 Thessaloniki, Greece.
  • Gavalas A; Division of Infectious Diseases, Weill Cornell Medicine, New York, NY 10065, USA.
  • Venugopala KN; School of Pharmacy, Aristotle, University of Thessaloniki, 54124 Thessaloniki, Greece.
  • Kochkar H; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
  • Emeka PM; Department of Biotechnology and Food Technology, Faculty of Applied Sciences, Durban University of Technology, Durban 4001, South Africa.
  • Younis NS; Department of Chemistry, College of Science, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia.
  • Elmaghraby DA; Basic & Applied Scientific Research Center, Imam Abdulrahman Bin Faisal University, Dammam 31441, Saudi Arabia.
  • Almostafa MM; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
  • Chohan MS; Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
  • Vizirianakis IS; Department of Pharmacy Practice, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
  • Papadimitriou-Tsantarliotou A; Department of Chemistry, College of Science, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
  • Geronikaki A; Biomedical Sciences Department, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia.
Molecules ; 28(8)2023 Apr 12.
Article in En | MEDLINE | ID: mdl-37110650
ABSTRACT
Major obstacles faced by the use of nonsteroidal anti-inflammatory drugs (NSAID) are their gastrointestinal toxicity induced by non-selective inhibition of both cyclooxygenases (COX) 1 and 2 and their cardiotoxicity associated with a certain class of COX-2 selective inhibitors. Recent studies have demonstrated that selective COX-1 and COX-2 inhibition generates compounds with no gastric damage. The aim of the current study is to develop novel anti-inflammatory agents with a better gastric profile. In our previous paper, we investigated the anti-inflammatory activity of 4-methylthiazole-based thiazolidinones. Thus, based on these observations, herein we report the evaluation of anti-inflammatory activity, drug action, ulcerogenicity and cytotoxicity of a series of 5-adamantylthiadiazole-based thiazolidinone derivatives. The in vivo anti-inflammatory activity revealed that the compounds possessed moderate to excellent anti-inflammatory activity. Four compounds 3, 4, 10 and 11 showed highest potency (62.0, 66.7, 55.8 and 60.0%, respectively), which was higher than the control drug indomethacin (47.0%). To determine their possible mode of action, the enzymatic assay was conducted against COX-1, COX-2 and LOX. The biological results demonstrated that these compounds are effective COX-1 inhibitors. Thus, the IC50 values of the three most active compounds 3, 4 and 14 as COX-1 inhibitors were 1.08, 1.12 and 9.62 µΜ, respectively, compared to ibuprofen (12.7 µΜ) and naproxen (40.10 µΜ) used as control drugs. Moreover, the ulcerogenic effect of the best compounds 3, 4 and 14 were evaluated and revealed that no gastric damage was observed. Furthermore, compounds were found to be nontoxic. A molecular modeling study provided molecular insight to rationalize the COX selectivity. In summary, we discovered a novel class of selective COX-1 inhibitors that could be effectively used as potential anti-inflammatory agents.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thiadiazoles / Antineoplastic Agents Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Molecules Journal subject: BIOLOGIA Year: 2023 Document type: Article Affiliation country: Arabia Saudita

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thiadiazoles / Antineoplastic Agents Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Molecules Journal subject: BIOLOGIA Year: 2023 Document type: Article Affiliation country: Arabia Saudita
...